Web-Based Reporting of Post-Vaccination Symptoms for Inactivated COVID-19 Vaccines in Jordan: A Cross-Sectional Study.
COVID-19
Jordan
coronavirus
inactivated COVID-19 vaccine
side effects
vaccines
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
25 Dec 2022
25 Dec 2022
Historique:
received:
05
11
2022
revised:
15
12
2022
accepted:
21
12
2022
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
The perception of COVID-19 vaccines as being unsafe is a major barrier to receiving the vaccine. Providing the public with accurate data regarding the vaccines would reduce vaccine hesitancy. A cross-sectional study was conducted to collect data on the side effects experienced by the vaccinated population to assess the safety of the inactivated COVID-19 vaccine. The majority of the study participants (n = 386) were female (71.9%), and 38.6% of them were under 30 years old. Around half of the participants (52.8%) reported side effects after receiving the inactivated COVID-19 vaccine. Fatigue (85.1%), a sore arm at the site of the injection (82.1%), and discomfort (67.2%) were the most commonly reported side effects after the first dose. Reporting side effects was significantly associated with the female sex ( Mild side effects were reported after receiving the inactivated COVID-19 vaccine. Fatigue was the most commonly reported side effect. Females, older adults, smokers, and those who had never been infected with COVID-19 had a greater susceptibility to certain side effects.
Sections du résumé
BACKGROUND
BACKGROUND
The perception of COVID-19 vaccines as being unsafe is a major barrier to receiving the vaccine. Providing the public with accurate data regarding the vaccines would reduce vaccine hesitancy.
METHODS
METHODS
A cross-sectional study was conducted to collect data on the side effects experienced by the vaccinated population to assess the safety of the inactivated COVID-19 vaccine.
RESULTS
RESULTS
The majority of the study participants (n = 386) were female (71.9%), and 38.6% of them were under 30 years old. Around half of the participants (52.8%) reported side effects after receiving the inactivated COVID-19 vaccine. Fatigue (85.1%), a sore arm at the site of the injection (82.1%), and discomfort (67.2%) were the most commonly reported side effects after the first dose. Reporting side effects was significantly associated with the female sex (
CONCLUSION
CONCLUSIONS
Mild side effects were reported after receiving the inactivated COVID-19 vaccine. Fatigue was the most commonly reported side effect. Females, older adults, smokers, and those who had never been infected with COVID-19 had a greater susceptibility to certain side effects.
Identifiants
pubmed: 36679889
pii: vaccines11010044
doi: 10.3390/vaccines11010044
pmc: PMC9866303
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Dermatol Ther. 2022 Sep;35(9):e15689
pubmed: 35789521
J Cosmet Dermatol. 2021 Dec;20(12):3753-3757
pubmed: 34741583
Hum Vaccin Immunother. 2022 Nov 30;18(5):2082792
pubmed: 35759219
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Front Public Health. 2022 May 16;10:896343
pubmed: 35651866
Vaccines (Basel). 2021 Oct 09;9(10):
pubmed: 34696264
Vaccines (Basel). 2022 Jan 25;10(2):
pubmed: 35214647
Int J Infect Dis. 2021 Oct;111:219-226
pubmed: 34384899
Vaccines (Basel). 2021 Apr 05;9(4):
pubmed: 33916489
Vaccines (Basel). 2022 Feb 16;10(2):
pubmed: 35214761
Metabol Open. 2021 Dec;12:100124
pubmed: 34541483
Arch Acad Emerg Med. 2022 Jul 7;10(1):e54
pubmed: 36033990
Cell Death Differ. 2021 Feb;28(2):626-639
pubmed: 33479399
Vaccines (Basel). 2022 Feb 09;10(2):
pubmed: 35214721
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102207
pubmed: 34280733
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Hum Vaccin Immunother. 2022 Dec 31;18(1):2039017
pubmed: 35240939
Clin J Oncol Nurs. 2010 Apr;14(2):E10-21
pubmed: 20350882
PLoS One. 2022 Feb 24;17(2):e0264371
pubmed: 35202444
PLoS One. 2020 Dec 3;15(12):e0243264
pubmed: 33270783
Vaccine X. 2022 Dec;12:100207
pubmed: 36032698
Vaccines (Basel). 2021 May 18;9(5):
pubmed: 34070196
Hum Cell. 2021 May;34(3):711-733
pubmed: 33677814
Annu Rev Cell Dev Biol. 2017 Oct 6;33:577-599
pubmed: 28992436
Hum Vaccin Immunother. 2022 Dec 31;18(1):1981086
pubmed: 34614383
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Vaccine. 2018 Jun 18;36(26):3861-3867
pubmed: 29605516
Radiology. 2003 May;227(2):309-13
pubmed: 12732691
Curr Opin Immunol. 2021 Aug;71:111-116
pubmed: 34330017
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
Vaccines (Basel). 2021 May 26;9(6):
pubmed: 34073382
Vaccines (Basel). 2019 Oct 18;7(4):
pubmed: 31635270
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676
Hum Vaccin Immunother. 2021 Aug 3;17(8):2415-2420
pubmed: 34014128
Vaccines (Basel). 2021 Nov 22;9(11):
pubmed: 34835300